Clinical trial
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients…
NCT00448136 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00448136 |
|---|---|
| Title | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract. |
| Official title | An Open Label Study to Evaluate the Effect of Avastin in Association With Chemotherapy on Progression-free Survival in Patients With Progressive Advanced/Metastatic Well-differentiated Digestive Endocrine Tumors of the Gastrointestinal Tract |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Drug |
| Interventions | bevacizumab [Avastin], 5 FU, Streptozotocin, Xeloda |
| Enrollment | 83 |
| Start date | Jul 1, 2007 |
| Primary completion | Nov 1, 2011 |
| Completion | Nov 1, 2011 |
| First posted | Mar 16, 2007 |
| Last update posted | Jan 22, 2015 |
| Countries | France |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: